Johnson & Johnson ends trial for HIV vaccine after data show it is ineffective

Published



Johnson & Johnson said Wednesday that it has ended a late-stage trial for its experimental HIV vaccine after data showed the shot was ineffective at preventing infections.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.